U.S. Markets close in 5 hrs 35 mins

Altimmune's stock soars after adding NASH candidate with purchase of Spitfire Pharma

Tomi Kilgore

Shares of Altimmune Inc. soared 14% in premarket trading Tuesday, after the biopharmaceutical company announced a deal to buy Spitfire Pharma Inc., which is developing a treatment for non-alcoholic steatohepatitis, known as NASH. Altimmune will make an upfront payment of $5 million to Spitfire shareholders, who will also be eligible to receive an additional $8 million in regulatory and clinical milestones and up to $80 million in sales-based milestones. The deal is expected to close in July. Spitfire's NASH product candidate SP-1373 will be renamed ALT-801. "Compelling preclinical data generated by Spitfire suggests that ALT-801 could reverse obesity, a primary cause of NASH, thereby reducing excess liver fat, inflammation and fibrosis associated with the disease," said Altimmune Chief Executive Vipin Garg. Altimmune's stock has tumbled 21.1% over the past three months through Monday, while the iShares Nasdaq Biotechnology ETF has lost 4.3% and the S&P 500 has gained 3.4%.

  • Should You Buy Hikma Pharmaceuticals PLC (LON:HIK) For Its Upcoming Dividend In 2 Days?
    Business
    Simply Wall St.

    Should You Buy Hikma Pharmaceuticals PLC (LON:HIK) For Its Upcoming Dividend In 2 Days?

    Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Hikma Pharmaceuticals PLC (LON:HIK) is about to go ex-dividend in just 2 days. Hikma Pharmaceuticals's upcoming dividend is US$0.14 a share, following on from the last 12 months, when the company distributed a total of US$0.38 per share to shareholders. Looking at the last 12 months of distributions, Hikma Pharmaceuticals has a trailing yield of approximately 1.6% on its current stock price of £20.01.

  • Is LGI Homes, Inc. (NASDAQ:LGIH) Overpaying Its CEO?
    Business
    Simply Wall St.

    Is LGI Homes, Inc. (NASDAQ:LGIH) Overpaying Its CEO?

    Eric Lipar became the CEO of LGI Homes, Inc. (NASDAQ:LGIH) in 2009. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. At the time of writing our data says that LGI Homes, Inc. has a market cap of US$1.7b, and is paying total annual CEO compensation of US$4.2m.

  • 3 Marijuana Stocks You Should Buy, According to This 124-Year-Old Wall Street Firm
    Business
    Motley Fool

    3 Marijuana Stocks You Should Buy, According to This 124-Year-Old Wall Street Firm

    CV Sciences: price target $5, representing 62% upside Considering Piper Jaffray's excitement concerning CBD growth in the United States – an industry that Lavery believes could reach $8 billion to $15 billion in annual sales in five years – it's no surprise that CV Sciences (OTC: CVSI) is Piper's second overweight pot stock. CV Sciences and its line of PlusCBD Oil products have had a number of big wins this year, with the creme-de-la-creme being its distribution partnership with Kroger (NYSE: KR), the nation's largest grocer.

  • How the Fed ‘could trigger carnage in the bond and equity markets’ this week
    Business
    Yahoo Finance

    How the Fed ‘could trigger carnage in the bond and equity markets’ this week

    The one bright spot in the economy, the strength of the U.S. consumer, could throw a wrench in the Fed's messaging this week, as central bankers gear up for an annual policy conference in Jackson Hole, Wyoming. “There is a risk [Fed Chair Jerome] Powell and his colleagues end up disappointing the bond market next week – by not signaling clearly enough that additional rate cuts are coming in mid-September and beyond,” Paul Ashworth, chief U.S. Economist at Capital Economics, wrote in a note to clients. Just last Thursday, July retail sales were released, a key data point on consumer health.

  • Trump Administration Asks Supreme Court to Permit Employment Discrimination Against Transgender Workers
    Politics
    Meredith Videos

    Trump Administration Asks Supreme Court to Permit Employment Discrimination Against Transgender Workers

    The Trump administration's Department of Justice is asking the Supreme Court to set a legal precedent that would enable employers to fire employees because they are transgender.

  • 3 Dividend Stocks Perfect for Retirees
    Business
    Motley Fool

    3 Dividend Stocks Perfect for Retirees

    Shell looks like a solid bet for retirees craving a reliable payout in their golden years. A rock-solid retailer Jeremy Bowman (Costco): It's no secret that the retail sector is struggling. Department store and mall-based chain stocks have tumbled amid a massive upheaval in the industry that has made e-commerce king.

  • These 4 Measures Indicate That Gold Resource (NYSEMKT:GORO) Is Using Debt Extensively
    Business
    Simply Wall St.

    These 4 Measures Indicate That Gold Resource (NYSEMKT:GORO) Is Using Debt Extensively

    Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. What Is Gold Resource's Net Debt?

  • A gun law case before the US Supreme Court has Americans up in arms
    Finance
    Quartz

    A gun law case before the US Supreme Court has Americans up in arms

    The US Supreme Court will soon consider the right to bear arms, something it hasn't done for nearly a decade. The case in question has pitted New York City against the New York State Pistol and Rifle Association over a law on transporting guns. The twist here is that New York City, and its many legal allies, say the case is actually moot.

  • Tilray, Inc. (NASDAQ:TLRY): Are Analysts Optimistic?
    Business
    Simply Wall St.

    Tilray, Inc. (NASDAQ:TLRY): Are Analysts Optimistic?

    Tilray, Inc.'s (NASDAQ:TLRY): Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The US$3.1b market-cap posted a loss in its most recent financial year of -US$67.7m and a latest trailing-twelve-month loss of -US$115.1m leading to an even wider gap between loss and breakeven. Many investors are wondering the rate at which TLRY will turn a profit, with the big question being “when will the company breakeven?” Below I will provide a high-level summary of the industry analysts' expectations for TLRY.

  • A Short-Seller Goes Too Far to Beat the ‘Bullies’
    Business
    Bloomberg

    A Short-Seller Goes Too Far to Beat the ‘Bullies’

    You won't find a better example of this than Cohodes's efforts over the last year to destroy — yes, destroy — MiMedx Group Inc., a biomedical company that makes products that heal wounds and treat serious inflammation. From 1985 to 2006, he partnered with another prominent short, David Rocker. Together, they uncovered wrongdoing at companies like AremisSoft Corp. and Conseco Inc. When Rocker retired in early 2007, Cohodes took over the firm, and renamed it Copper River Management LLC.

  • After the DowDuPont Split: An Investor’s Guide to the 3 New Companies
    Business
    Motley Fool

    After the DowDuPont Split: An Investor’s Guide to the 3 New Companies

    Let's break it down so investors -- especially those who owned DowDuPont stock and now own shares of all three companies -- know what's in their portfolios. The new Dow: Materially strong Market cap: $33.5 billion Focus: Performance chemicals, chemical additives, packaging While the old Dow and DuPont had many different product lines serving dozens of industries, the portfolios of both have been streamlined, leaving Dow with the bulk of the companies' "performance chemicals" assets. These include a lot of names with which you probably aren't familiar.

  • Business
    Market Exclusive

    Cannabis Stock News Daily Roundup August 19

    Dixie Brands (CSE: DIXI.U) (OTCQX: DXBRF) (Frankfurt: 0QV) announced that its pet wellness subsidiary Therabis launched its new new Mobility soft chew for dogs. The new soft is designed to promote joint health and a healthy inflammatory system in dogs. Industries (CSE: TGIF) (OTCQX: TGIFF) announced the grant of 6,800,000 incentive stock options to its directors, officers, consultants, and employees pursuant to the company's stock option plan.

  • Virgin plastic pellets are the biggest pollution disaster you’ve never heard of
    Finance
    Quartz

    Virgin plastic pellets are the biggest pollution disaster you’ve never heard of

    Some 30 miles north of Pittsburgh, Pennsylvania, in a township adjacent to a state forest, oil and gas giant Royal Dutch Shell is building a sprawling new plant to support what it sees as the future of its business: making millions of tons of new, virgin plastic. Shell, along with other major oil and gas companies like Exxon, sees plastic as one avenue for growth as natural gas prices plummet—and, longer-term, as a way to weather the world's slow rejection of fossil fuels as an energy source. For now, if Shell can't make money selling its plentiful natural gas, it can certainly make plastic with it.

  • Three 5G Stocks Poised to Soar Over the Next Decade
    Business
    Motley Fool

    Three 5G Stocks Poised to Soar Over the Next Decade

    That means next year could mark the beginning of a big Apple refresh cycle, leading to iPhone growth once again. Given Apple's very reasonable valuation, rising dividend, and share repurchases, its shareholders seem poised to win big from the 5G revolution. Taiwan Semiconductor and 5G Speaking of Apple, the smartphone giant is designing more and more of its own custom chips in-house these days, such as its A-series processors.

  • PayPal Is Still a Buy, Despite Its Recent Revenue Miss
    Business
    Motley Fool

    PayPal Is Still a Buy, Despite Its Recent Revenue Miss

    PayPal (NASDAQ: PYPL) investors were caught off guard recently when the company reported its second-quarter earnings. It has regularly beaten both its in-house forecast and investor expectations, and raised its guidance in the wake of its strong growth, but something was amiss this quarter. The payment processor reported revenue of $4.31 billion, up 12% year over year, and adjusted earnings per share of $0.86.

  • Do Directors Own Tellurian Inc. (NASDAQ:TELL) Shares?
    Business
    Simply Wall St.

    Do Directors Own Tellurian Inc. (NASDAQ:TELL) Shares?

    Every investor in Tellurian Inc. (NASDAQ:TELL) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. Warren Buffett said that he likes 'a business with enduring competitive advantages that is run by able and owner-oriented people'.

  • 13 Arrested as Far-Right Rally Clashes With Counter-Demonstrators in Downtown Portland
    U.S.
    Meredith Videos

    13 Arrested as Far-Right Rally Clashes With Counter-Demonstrators in Downtown Portland

    Hundreds of far-right protesters and anti-fascist counter-demonstrators swarmed downtown Portland, Oregon, on Saturday for a long-hyped rally that attracted President Donald Trump's attention and resulted in at least 13 arrests.

  • Better Buy: Eli Lilly vs. GlaxoSmithKline
    Business
    Motley Fool

    Better Buy: Eli Lilly vs. GlaxoSmithKline

    Eli Lilly (NYSE: LLY) and GlaxoSmithKline (NYSE: GSK) are undergoing transformations. Both big drugmakers have launched multiple new products to drive future growth while simultaneously dealing with sagging sales of older drugs. The companies' executions of these transformation efforts differ, though.

  • 3 Dividend Stocks That Should Pay You the Rest of Your Life
    Business
    Motley Fool

    3 Dividend Stocks That Should Pay You the Rest of Your Life

    There's a balance in the dividend space between high yields and dividend sustainability. In the end, it's generally more important to find stocks that can keep paying -- and hopefully increasing -- their dividends than to stretch for high yields that are ephemeral because they are backed by dividends that are likely to get cut. If you want to add a few good dividend names to your portfolio, these three Motley Fool contributors think you'll want to look at biotech Gilead Sciences (NASDAQ: GILD), telecom giant Verizon (NYSE: VZ), and consumer products specialist Procter & Gamble (NYSE: PG).

  • Investors Who Bought Novavax (NASDAQ:NVAX) Shares Three Years Ago Are Now Down 94%
    Business
    Simply Wall St.

    Investors Who Bought Novavax (NASDAQ:NVAX) Shares Three Years Ago Are Now Down 94%

    Because Novavax is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. Shareholders of unprofitable companies usually expect strong revenue growth. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

  • This High-Yield Stock Will Finally Give Investors a Raise in 2020
    Business
    Motley Fool

    This High-Yield Stock Will Finally Give Investors a Raise in 2020

    With cash flow on the rise and capital spending set to fall, it's on track to generate significant free cash flow after paying its 7.2%-yielding distribution next year. Because of that, the midstream company expects to start boosting the amount of money it delivers to its investors again for the first time since it cut the payout to its current level in 2016. That was clear from the comments of the company's management team on the recent second-quarter conference call.

  • Calculating The Fair Value Of Armstrong World Industries, Inc. (NYSE:AWI)
    Business
    Simply Wall St.

    Calculating The Fair Value Of Armstrong World Industries, Inc. (NYSE:AWI)

    Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Armstrong World Industries, Inc. (NYSE:AWI) as an investment opportunity by taking the expected future cash flows and discounting them to today's value. This is done using the Discounted Cash Flow (DCF) model. Remember though, that there are many ways to estimate a company's value, and a DCF is just one method.

  • Business
    U.S.News & World Report

    What Happens to Credit Card Debt When You Die?

    The executor of your estate, the person who carries out your wishes, will use your assets to pay off your credit card debts. But when your credit card debts have depleted your assets, your heirs can be left with little or no inheritance. If you are worried about loved ones being stuck with your debts after you die, make sure you understand your rights.

  • Pfizer (NYSE:PFE) Shareholders Have Enjoyed A 20% Share Price Gain
    Business
    Simply Wall St.

    Pfizer (NYSE:PFE) Shareholders Have Enjoyed A 20% Share Price Gain

    One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During five years of share price growth, Pfizer achieved compound earnings per share (EPS) growth of 6.6% per year. This EPS growth is higher than the 3.7% average annual increase in the share price.

  • This Oil Stock Continues to Prove It's a Cash Flow-Gushing Machine
    Business
    Motley Fool

    This Oil Stock Continues to Prove It's a Cash Flow-Gushing Machine

    The cash continues to flow Wallette pointed out on the call that "we generated $3.4 billion of cash from operations" during the second quarter. That was easily enough to cover the company's capital expenses, which totaled $1.7 billion in the quarter. As a result, the company produced $1.7 billion of free cash flow during the quarter, pushing its year-to-date total to $3 billion.